Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel-Reference-Cited by-同舟云学术

Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel

Published:2001-02 Issue:2 Volume:23 Page:205-212
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Queille-Roussel Catherine,Poncet Michel,Mesaros Stephane,Clucas Alan,Baker Michael,Soloff Andrew-Marc

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference11 articles.

1. Vehicle controlled study of CD 271 lotion in the topical treatment of acne vulgaris;Verschoore;J Invest Dermatol.,1993

2. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris;Verschoore;Br J Dermatol.,1991

3. Adapalene 0.1% gel has low skin-irritation potential;Verschoore;J Am Acad Dermatol.,1997

4. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients;Caron;J Am Acad Dermatol.,1997

5. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris. Europe and U.S. multicenter trials;Cunliffe;J Am Acad Dermatol.,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications;Current Pharmaceutical Design;2023-06

2. Topical Administration of Lactiplantibacillus plantarum (SkinDuoTM) Serum Improves Anti-Acne Properties;Microorganisms;2023-02-07

3. Patch Testing in Special Populations: a Review;Current Treatment Options in Allergy;2022-08-22

4. Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli;Cell Reports Medicine;2022-02

5. Isotretinoin-Delonix polymeric nanoparticles: Potentials for skin follicular targeting in acne treatment;International Journal of Pharmaceutics;2021-12